We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
04 May 2021 - 07 May 2021
Virtual Venue

Preliminary Predictive Criteria Identified for COVID-19 Cytokine Storm

By LabMedica International staff writers
Posted on 05 Jan 2021
Print article
Image: Preliminary Predictive Criteria Identified For COVID-19 Cytokine Storm (Photo courtesy of University of L’Aquila).
Image: Preliminary Predictive Criteria Identified For COVID-19 Cytokine Storm (Photo courtesy of University of L’Aquila).
While most of cases of COVID-19 are mild, a sizeable number of patients develop a severe acute hyperimmune response characterized by a cytokine storm (CS). Two forms of CS, hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), rely on well-established criteria to identify their occurrence.

Results from recent reports suggest that COVID-19-associated CS is a unique form of a hyperinflammatory response, which needs further clinical and laboratory characterization as well as classification criteria. Reports from COVID-19 cohorts and autopsies highlight significant diffuse inflammation and widespread tissue damage, such as renal, cardiac and muscular damage, in addition to pulmonary impairment.

Clinical Scientists from Temple University Hospital (Philadelphia, PA, USA) and their international colleagues studied 513 patients with a confirmed diagnosis of COVID-19 admitted from March 10 to April 1, 2020. All included patients had been hospitalized for up to one week prior to enrollment and demonstrated ground-glass opacity by high-resolution computerized tomography of the chest, as well as a reverse transcriptase PCR for COVID-19 RNA.

The team analyzed laboratory results for the first seven days of hospitalization for each patient and used logistic regression and principal component analysis to determine the predictive criteria. They then used a “genetic algorithm” to find the cutoffs for each laboratory result. They validated the criteria with a second cohort of 258 patients admitted from 18 April 2020 to 30 April 2020 The criteria included a newly devised consensus was based on worsening respiratory and elevation above threefold the upper normal level of at least two of the following markers: C reactive protein (CRP), ferritin, D-dimer, lactate dehydrogenase (LDH) and cardiac troponin.

The investigators reported that the criteria for macrophage activation syndrome, hemophagocytic lymphohistiocytosis and the HScore failed to identify cytokine storm associated with COVID-19. Instead, they used new criteria that included three clusters of laboratory results. These involved inflammation, cell death and tissue damage, and prerenal electrolyte imbalance. These criteria demonstrated a sensitivity of 0.85 and a specificity of 0.8. In addition, they were able to identify patients with longer hospitalization and increased mortality.

The COVID-cytokine storm (CS) group had significantly higher levels of ferritin, CRP and triglycerides, and decreased levels of albumin, all signs of systemic inflammation. Ferritin showed an odds ratio (OR) of 14, indicating an important role in COVID-CS. Strong inflammation was confirmed by the level of interleukin-6 (IL-6), which was elevated in most patients with COVID-19, but significantly higher in COVID-CS (35 pg/mL versus 96 pg/mL). The white blood cells, and especially neutrophils and monocytes, were significantly increased in the COVID-CS group, suggesting an active role of the innate immunity in the storm. The lymphocytes instead were decreased, with averages half of the normal lower limit, suggesting a functional depletion of the adaptive immunity.

Roberto Caricchio, MD, FACR, a Professor of Rheumatology and senior author of the study, said, “Interestingly the criteria could be grouped in three major pathological aspect of COVID-19 disease: inflammation, cell death and tissue damage and prerenal electrolyte imbalance. The patients who met the criteria had three times longer length of hospitalization and six times higher mortality. Importantly the vast majority of patients who met the criteria, did so within the first seven days and half of them at the time of admission. Therefore, the criteria are able to identify the cytokine storm very early during hospitalization.” The study was published on December 14, 2020 in the journal Annals of the Rheumatic Diseases.

Related Links:
Temple University Hospital

Gold Supplier
25-OH Vitamin D Control
Complete D
Gold Supplier
SARS-CoV-2, Flu A/B, and RSV Test
Gold Supplier
SARS-CoV-2 Rapid Test
Vivalytic SARS-CoV-2 Rapid 39 Minute Test
Preterm Delivery Test (phIGFBP-1)
Actim Partus 1ngeni

Print article
BIOHIT  Healthcare OY


Molecular Diagnostics

view channel
Image: Randox Discovery Diagnostic Analyzer Wins 2021 Red Dot Award for High Design Quality (Photo courtesy of Randox Laboratories)

Randox Discovery Diagnostic Analyzer Wins 2021 Red Dot Award for High Design Quality

Randox Laboratories’ (Crumlin, UK) Discovery, a diagnostic analyzer which can consolidate molecular and immunoassay testing on one compact benchtop platform, has received the 2021 Red Dot Award for High... Read more


view channel
Image: Eppendorf Centrifuge 5910 Ri (Photo courtesy of Eppendorf AG)

Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results

Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.